logo-1000

MEET OUR TEAM

Our experienced leadership team has carved a path over decades of academic and industry roles. At Onchilles, we are developing novel drugs leveraging new neutrophil and macrophage biology to induce apoptosis in cancer cells. We are motivated to confront unmet medical needs in the world with novel and compelling science.

Management and board of directors

COURT R. TURNER, JD

Cofounder and Executive Chair

KELVIN LI, PhD

Board Member

LEV BECKER, PhD

Cofounder and Board Member

CHRIS TWITTY , PhD

Chief Scientific Officer

PETER HABERZ , PhD

Vice President, Corporate Development

SONIA FEAU, PhD

Director of Biology

RAVINDRA GUJAR, PhD

Senior Scientist

CHANG CUI, PhD

Senior Scientist

LAURA HEALEY, MS

Sr Research Associate

LILIBET VALDOVINOS

Sr Research Associate

ASNA KHALID

Sr Research Associate

AREZOO ARI ARJMAND

Research Associate

scientific AND Clinical Advisors

ALAIN ALGAZI, MD

Clinical Advisor

JOHN TEIJARO, PhD

Scientific Advisor

JEFFREY HAGER, PhD

Scientific Advisor

MARC NASOFF, PhD

Scientific Advisor

DISCOVER YOUR PATH

Onchilles Pharma is looking for talented and
enthusiastic people to join our quest.

JOIN OUR QUEST!